Alerts will be sent to your verified email
Verify Email
BERLDRG
|
Beryl Drugs
|
Hind Bio Science
|
Unjha Formulations
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
5.44 % | 3.66 % | 10.34 % |
|
5yr average Equity Multiplier
|
2.12 | 3.76 | 1.62 |
|
5yr Average Asset Turnover Ratio
|
1.19 | 0.25 | 3.51 |
|
5yr Avg Net Profit Margin
|
1.13 % | -39.56 % | 1.88 % |
|
Price to Book
|
1.06 | 10.47 | 2.07 |
|
P/E
|
799.77 | 64.3 | 8.21 |
|
5yr Avg Cash Conversion Cycle
|
-589.78 Days | 197.57 Days | 18.8 Days |
|
Inventory Days
|
36.09 Days | 0.0 | 28.57 Days |
|
Days Receivable
|
112.55 Days | 198.39 Days | 41.04 Days |
|
Days Payable
|
964.25 Days | 104.32 Days | 53.92 Days |
|
5yr Average Interest Coverage Ratio
|
1.91 | -32.49 | 17.56 |
|
5yr Avg ROCE
|
7.2 % | -14.28 % | 19.44 % |
|
5yr Avg Operating Profit Margin
|
6.72 % | -38.68 % | 3.19 % |
|
5 yr average Debt to Equity
|
0.59 | 2.68 | 0.0 |
|
5yr CAGR Net Profit
|
19.3 % | n/a | 32.6 % |
|
5yr Average Return on Assets
|
1.98 % | -8.2 % | 6.62 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
27.48 % | 12.19 % | 36.92 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
1.1 % | 0.0 | 0.0 |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
|
Beryl Drugs
|
Hind Bio Science
|
Unjha Formulations
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|